A biotech company using AI to design peptide therapeutics for diseases like cancer.
About
ProteinQure is a clinical-stage biotechnology company that uses its proprietary computational platform, ProteinStudio™, to design novel peptide therapeutics. Their platform integrates machine learning, structural biology, and atomic-level simulations to create peptide-drug conjugates for diseases like cancer, with a focus on precise tissue and cell-specific delivery.
Tags
Total Employees
32
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ProteinQure do?
ProteinQure is a clinical-stage biotechnology company that uses its proprietary computational platform, ProteinStudio™, to design novel peptide therapeutics. Their platform integrates machine learning, structural biology, and atomic-level simulations to create peptide-drug conjugates for diseases like cancer, with a focus on precise tissue and cell-specific delivery.
How much funding has ProteinQure raised?
ProteinQure has raised a total of $16M in funding. The most recent round on record is Series A.
When was ProteinQure founded?
ProteinQure was founded in 2017.
How many employees does ProteinQure have?
ProteinQure has approximately 32 people on record.